EverGen: Speculative Turnaround Play on De-risked RNG Growth Pipeline and Strong Regulatory Tailwinds
EverGen Infrastructure Corp. (EVGN.V), self-described as "Canada's Renewable Natural Gas Infrastructure Platform," is an independent renewable energy producer. The company operates a vertically integrated business model focused on acquiring and processing organic waste, from which it generates revenue via municipal and commercial tipping fees, and converting that waste into two valuable end-products: Renewable Natural Gas (RNG) and organic compost.
The company's core assets include two operational RNG-producing facilities, Fraser Valley Biogas (FVB) in British Columbia and GrowTEC in Alberta, along with two organic waste processing facilities, Pacific Coast Renewables (PCR) and Sea to Sky Soils (SSS).
This analysis is anchored in the "transformational" events of May 2025. After a period of operational underperformance and significant non-cash impairments that damaged shareholder value, the company was recapitalized. This was achieved through a C$5 million private placement led by Ask America, LLC , which subsequently became the new "Control Person" of the company. This transaction installed a new, operationally-focused management team led by CEO Chase Edgelow.
The investment thesis centers on a deep disconnect between EverGen's current market valuation (approximately C$10.5 million) and its fundamental, de-risked potential. The market is pricing the company based on its poor historical track record, which includes significant non-cash impairments in 2024 and severe share price depreciation. This valuation appears to disregard three fundamental catalysts:
The installment of a new, highly aligned management team with a new, motivated controlling shareholder.
A tangible, fully-funded growth pipeline poised to more than double RNG production, headlined by a C$10.5 million non-dilutive grant from Natural Resources Canada (NRCan) for the company's flagship PCR expansion project.
A nascent strategic shift, evidenced in Q2 2025 results, to prioritize high-margin operations over simple revenue growth.
The investment case is a direct wager on this new team's ability to execute its de-risked project pipeline. Success would transition EverGen from a low-margin waste processor into a high-margin, stable RNG utility, a change that would necessitate a significant re-rating of its valuation multiples.
EverGen's integrated model is designed to capture value at two distinct points in the organic waste-to-energy cycle:
Waste Processing & Tipping Fees: The company charges municipalities and commercial clients "tipping fees" for receiving, processing, and disposing of organic waste. This segment currently constitutes the majority of the company's revenue.
RNG & Environmental Credit Sales: The organic feedstock is processed through anaerobic digestion to create biogas, which is then upgraded into pipeline-quality RNG. This RNG is sold under long-term, fixed-price offtake agreements, primarily to utilities like FortisBC. This process also generates valuable environmental credits under British Columbia's Low Carbon Fuel Standard (LCFS) and the federal Clean Fuel Regulations (CFR), providing a secondary, high-margin revenue stream.
In May 2025, Ask America, LLC became the new "Control Person" following a C0.60 per share. This recapitalized the balance sheet and installed a new leadership team tasked with executing a turnaround via a 100-day plan focused on operational optimization.
The first clear signal of this new strategy emerged in the Q2 2025 financial results. The company reported a 34% year-over-year revenue decline , a significant miss against analyst expectations. However, management commentary confirmed this was an "intentional reset". The previous management team's focus on revenue growth appears to have led to the acceptance of low- or negative-margin feedstock, which culminated in large non-cash impairments related to the Sea to Sky Soils facility in 2024.
The new team is deliberately "positioning the business to attract higher-value organic feedstock" and terminating unfavorable legacy contracts. The success of this strategic shift is evident: despite the 34% drop in revenue, the company remained Adjusted EBITDA positive at C$339,000. This demonstrates a new, disciplined focus on margin and profitability over top-line growth.
EverGen's value is transitioning from its legacy processing assets to its RNG-producing platform.
Operational RNG Facilities (Current Cash Flow):
Fraser Valley Biogas (FVB): The company's core cash-flow asset in British Columbia. Following an expansion in 2023, FVB is now approaching its full nameplate capacity of 160,000 GJ/year. It achieved robust monthly production of over 12,000 GJ in early 2025.
GrowTEC (Phase 1): An agricultural biogas facility in Alberta. Phase 1 is operational with a capacity of 80,000 GJ/year. Its output is fully contracted under 20-year (FortisBC) and 10-year (Irving Oil) offtake agreements.
Funded Growth Pipeline (Future Cash Flow):
GrowTEC (Phase 2): A planned expansion project to add approximately 60,000 GJ/year of capacity, bringing the facility's total output to 140,000 GJ/year.
Pacific Coast Renewables (PCR): This is the company's flagship growth project. Currently a standard organic processing facility, the planned RNG expansion is designed to produce approximately 185,000 GJ/year.
Legacy Processing Facilities:
Sea to Sky Soils (SSS): This composting facility was the source of a significant non-cash impairment in 2024. Under the new strategy, it is undergoing "optimization initiatives" and is now viewed as a source of feedstock for RNG facilities rather than a primary standalone value driver.
The company's growth strategy is notable for being substantially de-risked from a financing and policy perspective.
De-Risked Growth: The PCR expansion, the company's largest and most important project, is "fully funded". This is the result of a C$10.5 million non-dilutive funding award from Natural Resources Canada's (NRCan) Clean Fuels Fund. This grant, which is nearly equivalent to the company's entire market capitalization (C$10.54 million) , de-risks the project's capital cost and transforms the investment thesis from a question of "if they can fund it" to "if they can build it."
Regulatory Milestones: The PCR project continues to advance, having achieved a key regulatory milestone with support from the Abbotsford City Council in July 2025. The final regulatory step, authorization from the Agricultural Land Commission, is expected in the second half of 2025.
Competitive Advantage (Credit Stacking): EverGen's strategic footprint in British Columbia provides a unique competitive advantage. The province's mature LCFS program layers on top of the federal Clean Fuel Regulations (CFR). This "credit stacking" allows BC-based RNG projects to generate credits from two separate programs, making them potentially more lucrative than projects in any other Canadian jurisdiction.
Table: EverGen Asset & Project Pipeline (GJ/Year Capacity)
| Facility | Type | Status | Phase 1 Capacity (GJ/yr) | Funded Expansion (GJ/yr) | Total Potential (GJ/yr) | Key Offtake/Source |
| Fraser Valley Biogas (FVB) | RNG | Operational | 160,000 | 0 | 160,000 | |
| GrowTEC | RNG | Operational | 80,000 | 60,000 | 140,000 | FortisBC, Irving Oil [13, 19] |
| Pacific Coast Renewables (PCR) | RNG | Development | 0 | 185,000 | 185,000 | FortisBC [14], NRCan Grant |
| Total RNG Capacity | 240,000 | 245,000 | 485,000 | |||
| Sea to Sky Soils (SSS) | Organics | Operational | N/A | N/A | N/A | Feedstock source |
Fiscal Year 2024 (Ended Dec 31, 2024): The 2024 results illustrate the disconnect between underlying operations and accounting.
Revenue: Grew 69% to C8.4 million in 2023. This growth was driven by the FVB expansion project coming online and the commencement of RNG production at GrowTEC.
Adjusted EBITDA: Increased 269% to C0.8 million in 2023 , demonstrating significant operational leverage as high-margin RNG sales scaled.
Net Loss: Despite the strong operational performance, the company reported a large Net Loss of C$17.1 million. This loss was not operational but was "primarily due to non-cash impairment losses" associated with the Sea to Sky Soils and GrowTEC assets.
Q2 2025 (Ended June 30, 2025): The "Turnaround" Quarter
Revenue: C4.41 million analyst forecast. As noted, this was an intentional strategic reduction in low-margin tipping fee volumes.
RNG Production: In contrast to the revenue line, RNG production grew 17% year-over-year to a quarterly record of 49,297 GJ.
Adjusted EBITDA: C$339,000. Despite the 34% revenue collapse, the company remained Adjusted EBITDA positive, confirming the new "value over volume" strategy is successfully improving the margin profile.
Net Loss: C$1.95 million.
Cash: C5 million private placement completed in May 2025.
Debt: C13 million debt facility.
Working Capital: The company reported a C$1.45 million working capital surplus.
The balance sheet is not in a distressed position. The May 2025 recapitalization and the positive working capital surplus provide a stable platform and the necessary liquidity to execute the new business plan, bridge to the C$10.5M NRCan grant, and complete the debt refinancing.
Table: Key Financial Metrics (in C$ 000s)
Market Capitalization: C0.47 share price and 22.43 million shares outstanding).
Enterprise Value (EV): C25.66M (LT Debt) - C31.68 Million (using Q2 2025 balance sheet data ).
Multiples (TTM based on FY 2024 results):
P/Sales (TTM): ~0.74x
EV/Sales (TTM): ~2.2x
EV/EBITDA (TTM): ~10.9x (using C$2.9M Adj. EBITDA )
The TTM EV/EBITDA multiple of 10.9x appears reasonable when benchmarked against renewable power producer (10-12x) and environmental services (12.8x) comparables. However, this multiple is being applied to a small, historically mismanaged, and partially optimized asset base. The current valuation assigns zero value to the C$10.5 million NRCan grant and zero value to the 245,000 GJ/year of funded growth in the pipeline, which represents a >100% increase in production capacity. The valuation is pricing the past, not the future potential.
1. Execution Risk (Primary Risk): The entire bull thesis rests on the new management team's ability to deliver the GrowTEC Phase 2 and PCR RNG expansion projects on time and on budget. The company's prior track record is poor, marked by impairments, delays , and significant value destruction. A failure to execute would validate the market's current bearish stance and likely lead to insolvency.
2. Financial Risk: The company carries a C$25.7 million long-term debt load. While the recent recapitalization provides breathing room, any material project cost overruns or operational shortfalls could reignite the cash burn rate and force the company to seek highly dilutive equity financing at depressed prices.
3. Operational Risk: The company's core facilities are subject to physical and operational risks. These have materialized in the past, including a fire at the PCR facility in late 2024 and weather-related disruptions that impacted processing volumes. These events reduce tipping fee revenue and highlight the fragility of the current, pre-turnaround business.
1. Regulatory & Policy Dependency: The company's revenue model is highly dependent on government-mandated climate policies, which create the market for its products.
Federal CFR: The Clean Fuel Regulations (CFR) create a credit market that is a key revenue source. The 2024 average price of C$157.07/tonne is robust, but any future political change that weakens or repeals the CFR would be detrimental to project economics.
BC LCFS: The provincial program provides a "stacked" credit , significantly enhancing the economics of the FVB and PCR projects. This market is noted as being "illiquid" , which can lead to price volatility. A collapse in LCFS prices, similar to the one experienced in California's LCFS market , would severely impact revenue forecasts.
A key political risk, however, has been resolved in 2025. The new Canadian government repealed the highly unpopular consumer-facing "carbon tax" but explicitly kept and pledged to strengthen the industrial carbon price and the Clean Fuel Regulations (CFR). This is a net positive for EverGen, as it removes the political backlash against carbon pricing while solidifying the industrial credit market that EverGen sells into.
2. Interest Rate Environment: Sustained high interest rates in Canada increase the cost of capital. This has a direct impact on the C$13M FVB refinancing and raises the hurdle rates for future (post-PCR) projects. While high rates are a headwind, they also serve as a barrier to entry. High financing costs make it significantly harder for new, speculative RNG projects to get funded. This may strengthen the competitive position of companies like EverGen that have already secured non-dilutive grant funding for their main growth projects.
This analysis presents a bottom-up projection of potential financial outcomes. The core variable is the successful execution of the funded RNG production pipeline (GrowTEC Phase 2 and PCR), which would fundamentally transform the company's revenue mix and margin profile.
1. RNG Production Ramp: Based on company guidance. Total potential capacity is 485,000 GJ/yr (FVB: 160,000 , GrowTEC: 140,000 , PCR: 185,000 ).
2. RNG Revenue: We assume a blended price of C$15.00/GJ.
Provenance: This is a conservative blend. It combines the baseline contracted FortisBC voluntary biomethane rate (C$9.23/GJ as of July 2025) with the significant additional value from stacked environmental credits (CFR/LCFS).
3. Environmental Credits: The federal CFR credit price averaged C$157/tonne in 2024. We will use a conservative C$125/tonne in our Base Case to account for potential volatility, with sensitivities in the High and Low cases.
4. Tipping Fee Revenue: We assume this revenue stream, which had an approximate C$11M/year run-rate based on Q2 2025 results , grows conservatively at 3% per year in the Base Case as the company prioritizes margin over volume.
5. Margins: Adjusted EBITDA margins are projected to expand significantly from ~20% in 2024 to over 35-40% by 2030 as the high-margin, low-opex RNG revenue stream progressively replaces lower-margin tipping fees.
6. Share Count: The current base is 22.43 million shares. The model assumes no dilution in the Base and High cases, as the C$10.5M NRCan grant is assumed to fully fund the PCR expansion. The Low Case assumes a 50% dilutive capital raise.
7. Terminal Multiple: We apply a terminal EV/EBITDA multiple of 10.0x.
Provenance: This is a conservative multiple for a stable renewable power producer. Industry comparables suggest a range of 10-12x , with related environmental services valued at 12.8x.
Narrative: The new management team proves effective. The FVB refinancing is completed successfully in 2026. GrowTEC Phase 2 (bringing total GrowTEC capacity to 140k GJ/yr) comes online by EOY 2026. The fully-funded PCR project (185k GJ/yr) is constructed and begins injection by EOY 2027. The company is fully ramped to its 485,000 GJ/yr platform by 2028. No further equity dilution is required.
Key Fundamentals:
Total RNG Production: Ramps from 240,000 GJ in 2026 to 485,000 GJ by 2028.
RNG Revenue (at C3.6M to C$7.3M.
Tipping Fee Revenue: Grows from C12.7M.
Adj. EBITDA: Grows from ~C10.2M in 2030, driven by the margin-accretive shift to RNG.
Valuation (2030):
Projected 2030 Adj. EBITDA: C$10.2M
Terminal Multiple: 10.0x
Projected 2030 Enterprise Value: C$102.0M
Projected 2030 Net Debt: C$20.0M (assumes debt is paid down with free cash flow)
Projected 2030 Market Cap: C$82.0M
Projected 2030 Share Price (on 22.43M shares): C$3.66
Narrative: Flawless execution. The PCR project is fast-tracked and online by mid-2027. Environmental credit prices are stronger than expected (C20/GJ. Strong free cash flow allows for a small, accretive acquisition or a new project announcement by 2030.
Key Fundamentals:
Total RNG Production: Fully ramped to 485,000 GJ by 2027.
RNG Revenue (at C9.7M.
Tipping Fee Revenue: Grows to C$12.7M.
Adj. EBITDA: Expands rapidly to ~C$13.9M in 2030 due to higher commodity/credit pricing.
Valuation (2030):
Projected 2030 Adj. EBITDA: C$13.9M
Terminal Multiple: 11.0x (reflects a higher growth and margin profile)
Projected 2030 Enterprise Value: C$152.9M
Projected 2030 Net Debt: C$15.0M (faster paydown from FCF)
Projected 2030 Market Cap: C$137.9M
Projected 2030 Share Price (on 22.43M shares): C$6.15
Narrative: The new management team stumbles, repeating the failures of the past. The PCR project faces significant permitting or construction delays and is not online by 2030. The C75/t, hurting margins. The company burns through its cash and is forced to do a 50% dilutive equity raise in 2027 just to stabilize the core business.
Key Fundamentals:
Total RNG Production: Stagnates at 240,000 GJ (core assets only).
RNG Revenue (at C2.4M.
Tipping Fee Revenue: Stagnates at C$11.0M as optimization fails.
Adj. EBITDA: Remains depressed at ~C$2.5M in 2030.
Valuation (2030):
Projected 2030 Adj. EBITDA: C$2.5M
Terminal Multiple: 8.0x (a distressed multiple)
Projected 2030 Enterprise Value: C$20.0M
Projected 2030 Net Debt: C$25.0M (no FCF to pay down debt)
Projected 2030 Market Cap: -C$5.0M (Insolvency/Wipeout)
Projected 2030 Share Price (on 33.65M shares): C$0.00
TURNAROUND IN-PROGRESS
Management Alignment: (8/10)
Narrative: Alignment is now a key strength. The May 2025 C0.60/share creates a new, aligned "Control Person" who is incentivized to see the turnaround succeed, having invested at a price above the current market. Insider activity is exceptionally bullish, with 30 buys and 0 sells in the last 12 months. The new CEO also has direct share ownership.
Revenue Quality: (4/10, improving)
Narrative: The current revenue quality is low. Analysis of Q2 2025 financials suggests the majority of revenue is from volatile, lower-margin organic waste tipping fees. The potential quality is high (rated 9/10), as the entire growth pipeline is underpinned by long-term, fixed-price RNG offtake agreements. The score will improve as the revenue mix shifts.
Market Position: (7/10)
Narrative: EverGen is an established "platform" in the Canadian RNG space, particularly in the critical BC market. Its control of feedstock (PCR, SSS) and operational assets (FVB) provides an entrenched position. The "credit stacking" advantage in BC gives it a structural advantage over peers in other provinces.
Growth Outlook: (9/10)
Narrative: The growth outlook is the company's strongest attribute. The pipeline (GrowTEC Ph2, PCR) is set to add >245,000 GJ/yr of capacity, more than doubling the current operational footprint. Critically, the largest project (PCR) is "fully funded" by a C$10.5M non-dilutive government grant , making this growth tangible and de-risked from a financing perspective.
Financial Health: (3/10, improving)
Narrative: The company's financial health is historically poor, marked by high debt and cash burn. However, it is materially improving. The May 2025 recapitalization and a C$1.45M working capital surplus have stabilized the company. The "fully funded" status of PCR means this growth will not be a drain on the balance sheet. This score is low based on history, but the trajectory is positive.
Business Viability: (7/10)
Narrative: The core business of converting waste to RNG is highly viable and supported by durable macroeconomic (decarbonization) and political (CFR, LCFS) tailwinds. The political de-risking of the CFR further strengthens this. The viability risk is not in the model, but in the company's execution of it.
Capital Allocation: (6/10)
Narrative: The prior management team's track record on capital allocation was poor, leading to significant non-cash impairments. The new team's stated strategy is "cost optimization and capital discipline". Their first major move—intentionally cutting low-margin revenue in Q2 2025 —is a strong, positive indicator of a disciplined, value-focused approach.
Analyst Sentiment: (8/10)
Narrative: While coverage is sparse (which is typical for a micro-cap), the sentiment from covering analysts is uniformly bullish. Analyst targets of C2.25 suggest a deep disconnect with the current share price (C$0.47), implying they see the same fundamental value in the pipeline that this analysis has identified.
Profitability: (3/10)
Narrative: The company is not profitable on a net income basis, posting a C1.95M net loss in Q2 2025. However, it is profitable on an operating cash flow basis, generating C339,000 in the Q2 2025 turnaround quarter. Profitability is expected to scale with the high-margin RNG projects.
Track Record: (1/10)
Narrative: The company's public-market track record is poor, characterized by project delays, impairments , and significant shareholder value destruction. The 1-year return is -74.7%. An investment in EVGN is a bet that this track record is irrelevant following the May 2025 management and control change.
Overall Blended Score: 5.6 / 10
NEEDS EXECUTION
Investment Thesis: EverGen Infrastructure Corp. (EVGN.V) presents a deeply asymmetric, high-risk/high-reward investment opportunity. The market is pricing the company (C10.5M market cap) as a distressed, low-margin waste processor on a path to insolvency, a valuation based on its poor historical track record of cash burn and non-cash impairments.
This valuation appears to be fundamentally flawed, as it ignores the "transformational" pivot of May 2025. This pivot installed a new, highly-aligned management team and "Control Person" (Ask America, LLC) who are now executing a clear and logical turnaround strategy.
The market is assigning zero value to the company's fully-funded, de-risked growth pipeline. This pipeline, headlined by the C$10.5 million NRCan grant for the PCR project, is set to more than double the company's high-margin RNG production to approximately 485,000 GJ/year.
Catalysts:
Project Execution: Successful completion of the C$13 million FVB refinancing (expected Q3 2025).
PCR Milestones: Final authorization from the Agricultural Land Commission (expected H2 2025) and a final investment decision (FID) on the project.
Financial Inflection: A noticeable shift in revenue mix, where high-margin RNG/credit sales overtake tipping fees, leading to rapid Adjusted EBITDA expansion in 2026-2027.
Risks:
Execution Failure: The primary risk is that the new team fails to build the PCR project, invalidating the entire thesis.
Credit Price Collapse: The business model relies on stable pricing for LCFS/CFR credits. A market collapse would impair project economics.
Outlook: Our 5-year probability-weighted price target of C$3.55 suggests the company is significantly undervalued. This outcome is entirely contingent on the new management team's ability to execute and transition EverGen from a speculative developer into a stable, profitable RNG utility.
SPECULATIVE TURNAROUND
The stock is trading at C0.375 - C1.52) and 200-day (C$2.48) moving averages, confirming a "Strong Sell" signal. The 14-day Relative Strength Index (RSI) of 29.57 indicates the stock is technically oversold, reflecting recent selling pressure following the Q2 earnings release, where the strategic revenue drop was misinterpreted by the market. The short-term outlook is a conflict between abysmal technicals and a compelling fundamental turnaround story.
TECHNICALLY OVERSOLD
View EverGen Infrastructure Corp. (EVGN.V) stock page
Loading the interactive version of this report…